Scholarlink

<p>The surgical management of early-stage endometrial cancer has undergone significant refinement with the integration of molecular markers and the introduction of the International Federation of Gynaecology and Obstetrics (FIGO) 2023 classification. Minimally invasive hysterectomy with bilateral salpingo-oophorectomy remains the standard procedure. Sentinel lymph node biopsy has become the preferred approach for nodal assessment and has largely replaced systematic lymphadenectomy. Molecular classification enables more accurate risk stratification and increasingly informs surgical decision-making. Close coordination between surgical treatment and adjuvant therapy is essential to ensure optimal patient care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Operative Therapie des Endometriumkarzinoms im klinischen Stadium FIGO I/II

  • 期刊论文

  • 发表日期：

    2026年7月23日

查看全文
  • Christina Barbara Walter,
  • F.-A. Taran,
  • M. Müller,
  • M. Wallwiener

摘要

The surgical management of early-stage endometrial cancer has undergone significant refinement with the integration of molecular markers and the introduction of the International Federation of Gynaecology and Obstetrics (FIGO) 2023 classification. Minimally invasive hysterectomy with bilateral salpingo-oophorectomy remains the standard procedure. Sentinel lymph node biopsy has become the preferred approach for nodal assessment and has largely replaced systematic lymphadenectomy. Molecular classification enables more accurate risk stratification and increasingly informs surgical decision-making. Close coordination between surgical treatment and adjuvant therapy is essential to ensure optimal patient care.